Detalhe da pesquisa
1.
A growth-factor-activated lysosomal K+ channel regulates Parkinson's pathology.
Nature;
591(7850): 431-437, 2021 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33505021
2.
L1CAM is not associated with extracellular vesicles in human cerebrospinal fluid or plasma.
Nat Methods;
18(6): 631-634, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34092791
3.
GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders.
Mov Disord;
2024 Apr 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38610104
4.
Omics in Neurodegenerative Disease: Hope or Hype?
Trends Genet;
36(3): 152-159, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31932096
5.
Plasma MIA, CRP, and Albumin Predict Cognitive Decline in Parkinson's Disease.
Ann Neurol;
92(2): 255-269, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35593028
6.
Author Correction: A growth-factor-activated lysosomal K+ channel regulates Parkinson's pathology.
Nature;
592(7855): E10, 2021 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33790472
7.
The Post-GWAS Era: From Association to Function.
Am J Hum Genet;
102(5): 717-730, 2018 05 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29727686
8.
TMEM106B modifies TDP-43 pathology in human ALS brain and cell-based models of TDP-43 proteinopathy.
Acta Neuropathol;
142(4): 629-642, 2021 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34152475
9.
Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.
Mov Disord;
36(12): 2945-2950, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34480363
10.
A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression.
Am J Hum Genet;
101(5): 643-663, 2017 Nov 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29056226
11.
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia.
Ann Neurol;
85(6): 801-811, 2019 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30973966
12.
ADNC-RS, a clinical-genetic risk score, predicts Alzheimer's pathology in autopsy-confirmed Parkinson's disease and Dementia with Lewy bodies.
Acta Neuropathol;
140(4): 449-461, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32749525
13.
AAV-Mediated Progranulin Delivery to a Mouse Model of Progranulin Deficiency Causes T Cell-Mediated Toxicity.
Mol Ther;
27(2): 465-478, 2019 02 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30559071
14.
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis.
PLoS Med;
16(10): e1002931, 2019 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31603904
15.
Concomitant Alzheimer Disease Pathology in Parkinson Disease Dementia.
Ann Neurol;
93(5): 1045-1046, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36892304
16.
Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.
Hum Mol Genet;
25(13): 2681-2697, 2016 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27126638
17.
APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
Mov Disord;
33(2): 289-297, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29168904
18.
Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease.
Alzheimers Dement;
14(8): 1052-1062, 2018 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29604263
19.
Reply to: "Age-Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK-PD)".
Mov Disord;
37(2): 436-437, 2022 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35150470
20.
Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.
Mov Disord;
32(11): 1636-1640, 2017 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28906025